CCL2 and Hepatic fibrosis: Pharmacological inhibition of MCP-1 by mNOX-E36 can also significantly reduce the infiltration of Gr1hi monocytes in the process of acute and chronic liver injury and can reduce the degree of liver fibrosis in vivo [21, 30, 44].